EDGAR Filing Documents for 0001193125-23-199916

Form 8-K - Current report:

SEC Accession No. 0001193125-23-199916

Filing Date

2023-08-01

Accepted

2023-08-01 07:19:34

Documents

Period of Report

2023-07-31

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d532249d8k.htm iXBRL	8-K	77606
2	EX-2.1	d532249dex21.htm	EX-2.1	681973
3	EX-10.1	d532249dex101.htm	EX-10.1	58301
4	EX-99.1	d532249dex991.htm	EX-99.1	56783
5	EX-99.2	d532249dex992.htm	EX-99.2	31922
6	EX-99.3	d532249dex993.htm	EX-99.3	36990
	Complete submission text file	0001193125-23-199916.txt		1324829

Data Files

Seq	Description	Document	Type	Size
7	XBRL TAXONOMY EXTENSION SCHEMA	eqrx-20230731.xsd	EX-101.SCH	4401
8	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	eqrx-20230731_def.xml	EX-101.DEF	13380
9	XBRL TAXONOMY EXTENSION LABEL LINKBASE	eqrx-20230731_lab.xml	EX-101.LAB	22368
10	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	eqrx-20230731_pre.xml	EX-101.PRE	14283
12	EXTRACTED XBRL INSTANCE DOCUMENT	d532249d8k_htm.xml	XML	5533

Mailing Address 50 HAMPSHIRE STREET CAMBRIDGE MA 02139

Business Address 50 HAMPSHIRE STREET CAMBRIDGE MA 02139 (617) 315-2255

EQRx, Inc. (Filer) CIK: 0001843762 (see all company filings)

IRS No.: 861691173 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40312 | Film No.: 231129644
SIC: 2834 Pharmaceutical Preparations